G. Strauss

D. Kent, G. Strauss, L. Caprario, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Optimal therapy of malignant pleural effusions.

L. Kalish, D. Sugarbaker, T. Lynch, 1996, International journal of oncology.

Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

S J Mentzer, W G Richards, W. Richards, 1996, Annals of surgery.

Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma.

D. Sugarbaker, G. Strauss, S. Mentzer, 1992, The Annals of thoracic surgery.

Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis.

L. Recht, G. Strauss, D. Silver, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lung cancer screening and the surgical oncologist: the controversy.

G. Strauss, L. Dominioni, 1999, Surgical oncology clinics of North America.

Reply to A. Katz et al

R. Schilsky, J. Herndon, G. Strauss, 2009 .

Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging.

D. Sugarbaker, T. Lynch, G. Strauss, 1993, The Journal of thoracic and cardiovascular surgery.

Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.

N. Choi, D. Mathisen, J. Herndon, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of high-dose cisplatin plus ifosfamide as first-line followed by carboplatin as second-line treatment in epithelial ovarian carcinoma.

H. Hansen, G. Strauss, B. Lund, 1997, Gynecologic Oncology.

Perception, paradox, paradigm

G. Strauss, L. Dominioni, G M Strauss, 2000, Cancer.

Screening for lung cancer: An evidence-based synthesis.

G. Strauss, Gary M. Strauss, 1999, Surgical oncology clinics of North America.

A prospective study of reproductive factors, hormone use, and risk of lung cancer in postmenopausal women.

D. Feskanich, G. Strauss, C. Baik, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Do race and ethnicity predict survival in metastatic non-small cell lung cancer?

S. Weitzen, G. Strauss, K. Faricy-Anderson, 2010, Medicine and health, Rhode Island.

The epidemic of smoking-related adenocarcinoma of the lung: The role of the tobacco industry and filtered and low-tar cigarettes: PRS-01

A. Jemal, K. Cummings, G. Strauss, 2007 .

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.

W. Richards, D. Sugarbaker, D. Harpole, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma.

D. Sugarbaker, T. Lynch, G. Strauss, 1993, Chest.

The benefit of chemotherapy in elderly patients with small cell lung cancer

G. Strauss, L. Caprario, 2014, Expert review of anticancer therapy.

Cisplatin, 5‐fluorouracil, and etoposide for advanced non‐small cell lung cancer

L. Kalish, D. Sugarbaker, T. Lynch, 1993, Cancer.

Chest wall invasive non-small cell lung cancer: Patterns of failure and implications for a revised staging system

D. Sugarbaker, D. Harpole, G. Strauss, 1996, Annals of Surgical Oncology.

ChestX-rayScreening Improves OutcomeinLungCancer*

G. Strauss, 2017 .

Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with hepatocellular carcinoma (HCC) from a phase I study.

J. Sosman, I. Puzanov, A. Santoro, 2012 .

Adjuvant chemotherapy (AC) in stage IB non-small cell lung cancer (NSCLC): Long-term follow-up of Cancer and Leukemia Group B (CALGB) 9633.

R. Schilsky, D. Sugarbaker, D. Harpole, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preirradiation Chemotherapy of Supratentorial Malignant Primary Brain Tumors with Intracarotid cis‐Platinum (CDDP) and i.v. BCNU: A Phase II Trial

L. Recht, G. Strauss, T. Fitzgerald, 1990, American journal of clinical oncology.

Dimethyltriazenoimidazole carboxamide therapy of malignant glucagonoma.

G. Strauss, T. Aoki, S. Weitzman, 1979, Annals of internal medicine.

Phase II study of topotecan in metastatic non-small-cell lung cancer.

L. Kalish, T. Lynch, G. Strauss, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: a 9-year retrospective cohort study

L. Price, Jay-Jiguang Zhu, T. Dvorak, 2010, Journal of Neuro-Oncology.

The role of second-look laparotomy in the long-term survival in ovarian cancer.

G. Strauss, M. Tuxen, B. Lund, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Women and lung cancer: waiting to exhale.

G. Strauss, E. Baldini, 1997, Chest.

Effect of recombinant human interleukin‐3 on haematological recovery from chemotherapy‐induced myelosuppression

L. Kalish, G. Demetri, T. Lynch, 1994, British journal of haematology.

Treatment of advanced ovarian cancer with sequential combination chemotherapy

T. F. Halpin, G. Strauss, M. Costanza, 1987, Cancer.

Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy.

M. Rudnick, G. Strauss, R. Narins, 1984, Annals of internal medicine.

Use of tumor markers in lung cancer.

G. Strauss, A. Skarin, 1994, Hematology/oncology clinics of North America.

Como international conference position statement: lung cancer screening for early diagnosis 5 years after the 1998 Varese conference.

J. Jett, M. Freedman, G. Strauss, 2005, Chest.

Adjuvant chemotherapy of lung cancer: methodologic issues and therapeutic advances.

G. Strauss, 2005, Hematology/oncology clinics of North America.

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

David J Sugarbaker, Richard L Schilsky, R. Schilsky, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of KRAS mutations on adjuvant carboplatin/paclitaxel in surgically resected stage IB NSCLC: CALGB 9633.

Michael R. Green, P. Jänne, E. Vokes, 2010 .

Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.

W. Richards, D. Sugarbaker, T. Lynch, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of failure after trimodality therapy for malignant pleural mesothelioma.

D. Sugarbaker, A. Recht, G. Strauss, 1997, The Annals of thoracic surgery.

Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633.

R. Schilsky, D. Sugarbaker, J. Herndon, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research.

D. Sugarbaker, M. Langer, G. Strauss, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Measuring effectiveness of lung cancer screening: from consensus to controversy and back.

G. Strauss, G M Strauss, Gary M. Strauss, 1997, Chest.

Cisplatin vs. carboplatin-based chemoradiotherapy in patients >65 years of age with stage III non-small cell lung cancer.

M. Galsky, G. Strauss, J. Wisnivesky, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic Significance of Mucin and p53 Expression in Stage IB Non-small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

E. Vokes, R. Kratzke, G. Strauss, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic markers in resectable non-small cell lung cancer.

G. Strauss, 1997, Hematology/oncology clinics of North America.

Reproductive Factors, Hormone Use, and Risk for Lung Cancer in Postmenopausal Women, the Nurses' Health Study

F. Speizer, D. Feskanich, G. Strauss, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study

E. Halm, G. Strauss, J. Wisnivesky, 2011, BMJ : British Medical Journal.

Management of early-stage lung cancer: past, present, and future adjuvant trials.

G. Strauss, 2006, Oncology.

Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633.

D. Sugarbaker, J. Herndon, E. Vokes, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.

D. Sugarbaker, T. Lynch, D. Harpole, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized population trials and screening for lung cancer

G. Strauss, 2000, Cancer.

Creation of an epidemic: The tobacco industry (TI) and smoking-related adenocarcinoma (AD) of the lung

A. Jemal, K. Cummings, G. Strauss, 2007 .

The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.

Heber MacMahon, John K Field, Shaf Keshavjee, 2012, The Journal of thoracic and cardiovascular surgery.

Outcomes After Adjuvant Platinum-based Chemotherapy in Elderly NSCLC Patients with T4 Disease

E. Halm, G. Strauss, K. Sigel, 2013, Annals of Surgical Oncology.

cer in Postmenopausal Women, the Nurses' Health Study

F. Speizer, D. Feskanich, G. Strauss, 2010 .

Chest X‐ray screening for lung cancer: Overdiagnosis, endpoints, and randomized population trials

G. Strauss, L. Dominioni, 2013, Journal of surgical oncology.

Screening for lung cancer re-examined. A reinterpretation of the Mayo Lung Project randomized trial on lung cancer screening.

D. Sugarbaker, G. Strauss, R. Gleason, 1993, Chest.

PROGNOSTIC MARKERS CELL LUNG CANCER IN RESECTABLE NON-SMALL

G. Strauss, 1997 .

Extent of surgery and survival in early lung carcinoma

D. Sugarbaker, G. Strauss, 2000, Cancer.

A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.

D. Sugarbaker, T. Lynch, D. Kwiatkowski, 1995, Seminars in oncology.

High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234.

J. Herndon, G. Strauss, N. Vogelzang, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Carboplatin versus cisplatin-based adjuvant chemotherapy in elderly patients with stages IB, II, and IIIA non-small cell lung cancer in the community setting.

G. Strauss, J. Wisnivesky, F. Gu, 2013 .

Adjuvant vs neoadjuvant chemotherapy in resectable NSCLC: is that the real question?

G. Strauss, 2009, Oncology.

Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial

R. Herbst, B. Teicher, R. Salgia, 2001, Cancer Chemotherapy and Pharmacology.

Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.

J. Austin, H. MacMahon, R. Munden, 2012, The Journal of thoracic and cardiovascular surgery.

Consensus statement

G. Strauss, L. Dominioni, 2000 .

Could chest X‐ray screening for lung cancer be cost‐effective?

G. Strauss, J J Caro, W S Klittich, 2000, Cancer.

Differences in clinical trial patient attributes and outcomes according to enrollment setting.

B. McNeil, E. Lamont, N. Keating, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined high-dose platinum and etoposide in previously untreated ovarian cancer patients with residual disease

H. Hansen, G. Strauss, B. Lund, 1996, International Journal of Gynecologic Cancer.

Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer

G. Strauss, K. Propert, D. Budman, 1992, Cancer Chemotherapy and Pharmacology.

Advances in surgical staging and therapy of non-small-cell lung cancer.

D. Sugarbaker, G. Strauss, 1993, Seminars in oncology.

Efficacy in selected tumor types in a phase I study of the c-MET inhibitor ARQ 197 in combination with sorafenib.

J. Sosman, I. Puzanov, A. Adjei, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumour‐induced hypoglycaemia due to ‘big’ IGF–II

G. Strauss, L. Christensen, J. Zapf, 1994, Journal of internal medicine.

Reproductive Factors, Hormone Use, and Risk for Lung Cancer in Postmenopausal Women, the Nurses' Health Study

F. Speizer, D. Feskanich, G. Strauss, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Adjuvant Gamma Knife radiosurgery following surgical resection of brain metastases: a 9-year retrospective cohort study

L. Price, Jay-Jiguang Zhu, G. Strauss, 2010, Journal of Neuro-Oncology.

J. Austin, H. MacMahon, R. Munden, 2012, The Journal of thoracic and cardiovascular surgery.

Could chest X‐ray screening for lung cancer be cost‐effective?

G. Strauss, W. Klittich, J. Jaime Caro, 2000, Cancer.

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database

D. Kent, G. Strauss, L. Caprario, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The Mayo Lung Cohort: a regression analysis focusing on lung cancer incidence and mortality.

G. Strauss, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.